Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) filed a Form 8-K with the Securities and Exchange Commission on February 23, 2026, disclosing a material event.
Oric Pharmaceuticals, Inc.'s stock currently trades at $11.71 with a market capitalization of $944.7M. The Healthcare company's stock moved following the disclosure.